Life Sciences Mergers and Acquisitions: A Vital Bridge Across the “Valley of Death” 

by Hanna | Nov 7, 2023 | Blog Post

Every day, life sciences innovators discover promising new therapies with the potential to transform our approach to treating life-altering or life-threatening diseases. But what lies between these initial discoveries and an FDA-approved treatment reaching patients is...

M&A Provides Vital Bridge for Life Science Innovation Amid Economic Headwinds, Market Demands 

by Hanna | Oct 30, 2023 | Blog Post

In one of the more challenging investment economies in decades, life science innovators are increasingly forced to face difficult economic headwinds and market demands in their pursuit of breakthrough treatments and cures.  The life sciences industry weathers...

In Case You Missed It: American Enterprise Institute Panelists Weigh in on FTC & DOJ’s Flawed Approach to Merger Enforcement 

by Hanna | Oct 26, 2023 | Blog Post

Following the public comment period on the FTC and DOJ’s proposed merger guidelines, leading antitrust experts and economists expressed significant concerns about the dramatic shift in competition policy that the proposal represents. In a recent panel discussion...

U.S. Chamber of Commerce Survey: Regulators’ Proposed Approach to M&A Ignores Market Reality

by Hanna | Oct 24, 2023 | Blog Post

A recent survey by the U.S. Chamber of Commerce sheds new light on the flaws of the Federal Trade Commission (FTC) and Department of Justice’s (DOJ) proposed approach to review and enforcement of mergers and acquisitions (M&A). The agencies’ two proposals – the...

What They Are Saying: Proposed Premerger Review Rules Would Burden Life Sciences Innovators, Impede Vital New Therapies 

by Hanna | Oct 12, 2023 | Blog Post

In a sharp departure from longstanding precedent, the Federal Trade Commission (FTC) and Department of Justice (DOJ) have proposed substantial changes to the existing guidelines and rules for antitrust enforcement. The set of proposals – specifically, the revised 2023...

What They Are Saying: Proposed Merger Guidelines Would Stall Innovation, Slowing Treatments and Cures for Patients 

by Hanna | Oct 12, 2023 | Blog Post

In a sharp departure from longstanding precedent, the Federal Trade Commission (FTC) and Department of Justice (DOJ) have proposed substantial changes to the existing guidelines and rules for antitrust enforcement. The set of proposals – specifically, the revised 2023...

Politico Op-ed: The Justice Department Controversy You Might Have Missed 

by Hanna | Oct 11, 2023 | Blog Post

In a recent op-ed for Politico, Ankush Khardori, an attorney and former federal prosecutor for the Department of Justice (DOJ), points out the noticeable lack of evidence behind the DOJ and Federal Trade Commissions’ (FTC) proposed merger guidelines.  ...